|Table of Contents|

Influencing factors investigation of cardiovascular adverse events related to minimally invasive surgery under artificial pneumothorax in elderly patients with esophageal cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2022 01
Page:
65-67
Research Field:
Publishing date:

Info

Title:
Influencing factors investigation of cardiovascular adverse events related to minimally invasive surgery under artificial pneumothorax in elderly patients with esophageal cancer
Author(s):
YANG Jinhua
General Thoracic Surgery,No.1 Affiliated Hospital of Nanyang Medical College,Henan Nanyang 473000,China.
Keywords:
elderly; esophageal cancer; pneumothorax; surgery; cardiovascular adverse events; influencing factors
PACS:
R735.1
DOI:
10.3969/j.issn.1672-4992.2022.01.014
Abstract:
Objective:To investigate the influencing factors investigation of cardiovascular adverse events related to minimally invasive surgery under artificial pneumothorax in elderly patients with esophageal cancer.Methods:Clinical data of 273 elderly patients with esophageal cancer by minimally invasive surgery under artificial pneumothorax were retrospectively chosen in the period from January 2010 to June 2017 and divided into 2 groups including 21 patients with cardiovascular adverse events related to surgery as A group and 252 patients without cardiovascular adverse events related to surgery as B group.Single-factor and multi-factor analysis were used to evaluate the influencing factors of cardiovascular adverse events related to surgery.Results:21 patients had cardiovascular adverse events related to surgery in 273 patients and the incidence was 7.69%.The proportion of ASA>III grade,clinical risk factors >3,hemodynamic fluctuation amplitude≥30%,airway pressure>30 cmH2O and CVP＞20 cmH2O of A group were significantly lower than B group（P＜0.05）.The results of Logistic regression model showed that ASA＞III grade,clinical risk factors＞3,hemodynamic fluctuation amplitude≥30% of basic value and CVP＞20 cmH2O were all independent risk factors of cardiovascular adverse events related to surgery（P＜0.05）.Conclusion:The occurrence of cardiovascular adverse events in the elderly patients with esophageal cancer is closely related to ASA classification,clinical risk factors,hemodynamic fluctuation range and CVP level,which can be used as the satisfactory clinical early warning index.

References:

[1]OHI M,TOIYAMA Y,OMURA Y,et al.Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer ［J］.Surg Today,2019,49(2):176-186.
[2]NACHIRA D,MEACCI E,MASTROMARINO MG,et al.Initial experience with uniportal video-assisted thoracic surgery esophagectomy ［J］.J Thorac Dis,2018,10(Suppl 31):S3686-S3695.
[3]SCHMIDT HM,GISBERTZ SS,MOONS J,et al.Defining benchmarks for transthoracic esophagectomy:A multicenter analysis of total minimally invasive esophagectomy in low risk patients ［J］.Ann Surg,2017,266(5):814-821.
[4]ALDERSON D,CUNNINGHAM D,NANKIVELL M,et al.Neoadjuvant cisplatin and fluorouracil versus epirubicin,cisplatin,and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05):an open-label,randomised phase 3 trial ［J］.Lancet Oncol,2017,18(9):1249-1260.
[5]赫捷.食管癌规范化诊治指南［M］.北京:中国协和医科大学出版社,2013:86-90. HE J.Guidelines for standardized diagnosis and treatment of esophageal cancer ［M］.Beijing:China Union Medical University Press,2013:86-90.
[6]JIN D,YAO L,YU J,et al.Robotic-assisted minimally invasive esophagectomy versus the conventional minimally invasive one:A meta-analysis and systematic review ［J］.Int J Med Robot,2019,15(3):e1988.
[7]CHAO YK,WEN YW,CUANG WY,et al.Transition from video-assisted thoracoscopic to robotic esophagectomy:a single surgeon's experience ［J］.Dis Esophagus,2019,25(4):33-41.
[8]CHAO YK,LI ZG,WEN YW,et al.Robotic-assisted esophagectomy vs video-assisted thoracoscopic esophagectomy(REVATE):study protocol for a randomized controlled trial ［J］.Trials,2019,20(1):346-352.
[9]CHAI T,SHEN Z,CHEN S,et al.Right versus left thoracic approach oesophagectomy for oesophageal cancer:a systematic review and meta-analysis protocol［J］.BMJ Open,2019,9(7):e030157.
[10]HAYASHI M,TAKEUCHI H,NAKAMURA R,et al.Determination of the optimal surgical procedure by identifying risk factors for pneumonia after transthoracic esophagectomy ［J］.Esophagus,2019,9(3):210-217.
[11]CHEN J,LIU Q,ZHANG X,et al.Comparisons of short-term outcomes between robot-assisted and thoraco-laparoscopic esophagectomy with extended two-field lymph node dissection for resectable thoracic esophageal squamous cell carcinoma ［J］.J Thorac Dis,2019,11(9):3874-3880.
[12]SALEM AI,THAU MR,STROM TJ,et al.Effect of body mass index on operative outcome after robotic-assisted Ivor-Lewis esophagectomy:retrospective analysis of 129 cases at a single high-volume tertiary care center ［J］.Dis Esophagus,2017,30(1):1-7.
[13]YANG X,ZHAN C,SUN F,et al.Efficacy comparison of Sweet versus Ivor-Lewis esophagectomy in the treatment of middle-lower esophageal squamous cell carcinoma ［J］.Chinese Journal of Surgery,2016,19(9):979-984.
[14]AKIYAMA Y,SASAKI A,ENDO F,et al.Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer:a retrospective cohort analysis ［J］.World J Surg Oncol,2018,16(1):122-127.
[15]NAKAJIMA M,MUROI H,KIKUCHI M,et al.Salvage esophagectomy combined with partial aortic wall resection following thoracic endovascular aortic repair ［J］.Gen Thorac Cardiovasc Surg,2018,66(12):736-743.
[16]GOENSE L,VAN DIJK WA,GOVAERT JA,et al.Hospital costs of complications after esophagectomy for cancer ［J］.Eur J Surg Oncol,2017,43(4):696-702.

Memo

Memo:
-
Last Update: 2021-12-02